812 related articles for article (PubMed ID: 25214461)
1. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.
Tan TZ; Miow QH; Miki Y; Noda T; Mori S; Huang RY; Thiery JP
EMBO Mol Med; 2014 Oct; 6(10):1279-93. PubMed ID: 25214461
[TBL] [Abstract][Full Text] [Related]
2. An individualized transcriptional signature to predict the epithelial-mesenchymal transition based on relative expression ordering.
Chen T; Zhao Z; Chen B; Wang Y; Yang F; Wang C; Dong Q; Liu Y; Liang H; Zhao W; Qi L; Xu Y; Gu Y
Aging (Albany NY); 2020 Jul; 12(13):13172-13186. PubMed ID: 32639951
[TBL] [Abstract][Full Text] [Related]
3. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
[TBL] [Abstract][Full Text] [Related]
4. Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT.
Lee J; Kim H; Lee JE; Shin SJ; Oh S; Kwon G; Kim H; Choi YY; White MA; Paik S; Cheong JH; Kim HS
Gastroenterology; 2018 Sep; 155(3):799-814.e13. PubMed ID: 29775598
[TBL] [Abstract][Full Text] [Related]
5. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
Fortunato A
Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
[TBL] [Abstract][Full Text] [Related]
6. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120).
Huang RY; Kuay KT; Tan TZ; Asad M; Tang HM; Ng AH; Ye J; Chung VY; Thiery JP
Oncotarget; 2015 Sep; 6(26):22098-113. PubMed ID: 26061747
[TBL] [Abstract][Full Text] [Related]
7. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
8. SMAD3 inducing the transcription of STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel.
Shi Y; Zhang J; Liu M; Huang Y; Yin L
J Cell Biochem; 2019 Jun; 120(6):10796-10811. PubMed ID: 30701575
[TBL] [Abstract][Full Text] [Related]
9. Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages.
Wang D; Haley JD; Thompson P
BMC Cancer; 2017 Dec; 17(1):830. PubMed ID: 29212455
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition.
Du L; Yamamoto S; Burnette BL; Huang D; Gao K; Jamshidi N; Kuo MD
Cancer Med; 2016 Aug; 5(8):1962-72. PubMed ID: 27318801
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling reveals epithelial mesenchymal transition (EMT) genes can selectively differentiate eribulin sensitive breast cancer cells.
Dezső Z; Oestreicher J; Weaver A; Santiago S; Agoulnik S; Chow J; Oda Y; Funahashi Y
PLoS One; 2014; 9(8):e106131. PubMed ID: 25171249
[TBL] [Abstract][Full Text] [Related]
13. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
14. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
15. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
Yu J; Xie F; Bao X; Chen W; Xu Q
Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
[TBL] [Abstract][Full Text] [Related]
16. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
Nakamura K; Terai Y; Tanabe A; Ono YJ; Hayashi M; Maeda K; Fujiwara S; Ashihara K; Nakamura M; Tanaka Y; Tanaka T; Tsunetoh S; Sasaki H; Ohmichi M
Oncol Rep; 2017 Jun; 37(6):3189-3200. PubMed ID: 28440503
[TBL] [Abstract][Full Text] [Related]
17. Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy.
Thompson JC; Hwang WT; Davis C; Deshpande C; Jeffries S; Rajpurohit Y; Krishna V; Smirnov D; Verona R; Lorenzi MV; Langer CJ; Albelda SM
Lung Cancer; 2020 Jan; 139():1-8. PubMed ID: 31683225
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of aquaporin 5-mediated epithelial-mesenchymal transition and anti-metastatic effect by natural product Cairicoside E in colorectal cancer.
Chen C; Ma T; Zhang C; Zhang H; Bai L; Kong L; Luo J
Mol Carcinog; 2017 Dec; 56(12):2692-2705. PubMed ID: 28833571
[TBL] [Abstract][Full Text] [Related]
19. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530).
Huang RY; Wong MK; Tan TZ; Kuay KT; Ng AH; Chung VY; Chu YS; Matsumura N; Lai HC; Lee YF; Sim WJ; Chai C; Pietschmann E; Mori S; Low JJ; Choolani M; Thiery JP
Cell Death Dis; 2013 Nov; 4(11):e915. PubMed ID: 24201814
[TBL] [Abstract][Full Text] [Related]
20. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.
Rokavec M; Bouznad N; Hermeking H
Cell Mol Gastroenterol Hepatol; 2019; 7(4):783-802. PubMed ID: 30831320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]